OTC
Stock Review is not a Registered Investment Advisor or a
Broker/Dealer. Furthermore, all information and/or opinions
throughout this site are presented solely for informative purposes,
and are not intended, nor should they be construed as investment
advice. This site is a publication and service of OTC Stock Review,
an independent research and investor-relations consulting firm that
publishes investment-research reports and profiles on independently
selected companies. Additionally, OTC Stock Review serves as a third
party consultant to the Companies profiled and receives fees either
in cash, stock or a combination thereof, for the services it
provides, including reimbursed expenses for preparation and
distribution of materials included in profiling the company. In this
regard, please see below for specific amounts of compensation that
OTC Stock Review received in profiling a specific company. Officers,
directors, and employees of OTC Stock Review, may hold a long or
short equity position of a profiled Company and may from time to
time trade in these securities for their own accounts. The
information available on this site is not an offer to buy or sell
securities of the Companies profiled on this release. Information
disclosed in this release is subject to change without notice.
Information pertaining to each Company profiled on this site was
provided to OTC Stock Review, by the Company and cannot be
guaranteed by OTC Stock Review. Companies profiled herein, including
those companies listed on the website's "Watch List" or
"News List" section, carry a high investment risk; readers
should carefully review the profiled Companies thoroughly with their
investment advisor, stockbroker, or other such professional.
Additionally, the "Watch List" and "News List"
profiled on the website is not a "buy list" in that there
will be no buy or sell recommendations issued by OTC Stock Review on
companies profiled in any form. OTC Stock Review is not liable for
any investment decisions by its readers or their advisors. Any
analysis contained herein does not purport to be a complete analysis
of the profiled Companies. Opinions stated are those of the
indicated sources and not necessarily those of either OTC Stock
Review or the Company being profiled on this site. Readers are
encouraged to obtain copies of the profiled Company's periodic
reports filed with United States Securities and Exchange Commission,
which are generally available at http://www.sec.gov.
OTC
Stock Review has been compensated $5,000.00 and $10,000.00 in
restricted shares to perform investor
relations services for Powerlinx (PWNX).
OTC
Stock Review has been compensated $4,500.00 and 20,000 restricted
shares to perform investor
relations services for Vubotics, Inc. (OTCBB: VBTC).
OTC
Stock Review has been compensated $12,500.00 to perform investor
relations services for Coffee Pacifica (OTCBB: CFPC).
OTC
Stock Review has been compensated $12,500.00 to perform investor
relations services for U.S. Geothermal, Inc. (OTCBB: UGTH)(TSX-V:
GTH).
OTC
Stock Review has been compensated $12,500.00 to perform investor
relations services for U.S. Geothermal, Inc. (OTCBB: UGTH)(TSX-V:
GTH).
OTC
Stock Review has been compensated $5,000.00 and $10,000.00 in
restricted shares to perform investor
relations services for Liska Biometry (OTCBB: LSKA).
OTC
Stock Review has been compensated $12,500.00 to perform investor
relations services for Viking Power Services, Inc. (OTCBB: VKPW).
A
principal of OTC
Stock Review has been compensated 60,000 restricted shares to perform investor
relations services for Utix Group, Inc. (OTCBB: UTIX).
A principal of OTC Stock
Review was compensated 400,000 shares restricted under rule 144 to perform Investor
Relations services for National Quality Care, Inc.
OTC
Stock Review has been compensated $10,000.00 to perform investor
relations services for Xinhua China, LTD.
OTC
Stock Review has been compensated $10,000.00 to perform investor
relations services for Coffee Pacifica Inc.
OTC
Stock Review has been compensated $8,000.00 to perform investor
relations services for Utix Group, Inc.
A principal of OTC Stock
Review owns 100,000 shares of Road House Foods acquired as
compensation for consulting services.
OTC
Stock Review has been compensated $6,000.00 to perform investor
relations services for Avalon
Oil and Gas, Inc. and a company controlled by an officer of OTC
Stock Review has been compensated 10,000,000 restricted shares for consulting services.
OTC
Stock Review has been compensated $10,000.00 to perform investor
relations services for Tradequest
International dba InComm Holdings.
OTC
Stock Review has been compensated $10,000.00 to perform investor
relations services for MGN
Holdings.
OTC
Stock Review has been compensated $10,000.00 in restricted stock to perform investor
relations services for Universal
Detection Technology.
OTC
Stock Review has been compensated $10,000.00 to perform investor
relations services for 5G
Wireless Communications, Inc.
OTC
Stock Review has been compensated $22,500.00 to perform investor
relations services for Adanac
Moly Corp.
OTC
Stock Review has been compensated $22,500.00 to perform investor
relations services for Goldrea
Resources.
OTC
Stock Review has been compensated $7,500.00 to perform investor
relations services for Signalife,
Inc.
OTC
Stock Review has been compensated $7,500.00 to perform investor
relations services for American
Oriental Bioengineering.
OTC Stock Review has been compensated $10,000.00 by a third-party to perform investor relations services for New Century.
This
site contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
and such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. "Forward-looking statements" describe future
expectations, plans, results, or strategies and are generally
preceded by words such as "may," "future,"
"plan" or "planned," "will" or
"should," "expected," "anticipates,"
"draft," "eventually" or "projected".
You are cautioned that such statements are subject to a multitude of
risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a companies' annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements on this
site are made as of the date hereof and OTCSR undertakes no
obligation to update such statements.
